Otolaryngology Doctors in Renton, WA Accepting Medicare

6 Otolaryngology doctors found. Showing 1 - 6

Scott Lungchi Lee, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 4033 Talbot Rd S, Ste 540, Renton, WA 98055 Phone: 206-575-2602    Fax: 206-575-2607

Mr. Martin R Greget, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 401 South 43rd St, 200, Renton, WA 98055 Phone: 425-656-4060    Fax: 425-656-4059

Charles H Caplan, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 4033 Talbot Rd S, Ste 230, Renton, WA 98055 Phone: 425-656-4200    Fax: 425-656-4258

Alan W Langman, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 9714 3rd Ave Ne Suite 100, Renton, WA 98115 Phone: 206-523-5584    Fax: 206-523-5882

Annie Kyunga Ahn, Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 4033 Talbot Rd S Ste 540, Renton, WA 98055 Phone: 425-690-3602    Fax: 425-690-9602

Bryan Samuel Serkin, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 4033 Talbot Rd S, Ste 540, Renton, WA 98055 Phone: 206-575-2602    Fax: 206-575-2607

News Archive

Children with high BMI have adverse heart disease risk factors at adolescence

Children who have a high body mass index (BMI) between 9 and 12 years of age are more likely to have high blood pressure, cholesterol and blood insulin levels (all risk factors for developing heart disease) by the time they reach adolescence, according to a study published today.

Scientists harness rabies viruses for assessing connectivity of nerve cell transplants

Scientists under the leadership of the University of Bonn have harnessed rabies viruses for assessing the connectivity of nerve cell transplants: coupled with a green fluorescent protein, the viruses show where replacement cells engrafted into mouse brains have connected to the host neural network.

Japan's automobile law improves air quality, reduces asthma-related deaths

A law passed in Japan in 1992 aimed to improve urban air quality by banning vehicles that violated certain emission standards from being registered in designated areas.

Telmisartan reduces hypertension, cardiovascular risk in ACE-intolerant patients: Boehringer Ingelheim

Telmisartan, an angiotensin receptor blocker, is one of the best researched drugs worldwide. It has been studied in clinical trials in more than 50,000 patients. Its positive safety profile has been confirmed also in a market exposure of 34.5 million patient years. Convincing safety data for patients with a high cardiovascular risk were collected in the three long-term outcome trials ONTARGET, PRoFESS and TRANSCEND which followed some of the patients for up to five years.

Read more Medical News

› Verified 7 days ago